Last updated on February 2018

Evaluation of Diagnostic Performance of VisioCyt Test in Case of Suspicion of Urothelial Bladder Tumors


Brief description of study

This clinical study is designed to evaluate the diagnostic performance of VisioCyt test, which would improve the early diagnosis of bladder cancer in order to optimize the management of individual patients as part of a cancer diagnostic monitoring. The diagnostic method of VisioCyt device is based on the analysis by transmission and fluorescence, of urinary cytology slides prepared according to the protocol VisioCyt.

Detailed Study Description

This clinical trial is divided into two main phases:

I. The first one involves the construction of better image processing algorithm from a learning sample. The learning sample will include 600 virtual slides made from the urine sample of the first 600 patients enrolled.

II. The second one, will evaluate from an evaluation sample, the diagnostic performance of the test VisioCyt, to identify patients with versus without bladder tumors, using as comparator the results of the examination of reference: histology. The evaluation sample will include 400 slides, made from the urine sample of the last 400 patients enrolled.

Clinical Study Identifier: NCT02966691

Contact Investigators or Research Sites near you

Start Over

Yannick ROUACH, Dr

H pital d'Antony
Antony, France
  Connect »

Laurent SAVAREUX, Dr

Clinique " la Ch taigneraie "
Beaumont, France
  Connect »

Laurent GUY, Dr

CHU de Clermont-Ferrand
Clermont-Ferrand, France
  Connect »

Marc COLOMBEL, Dr

H pital Edouard Herriot
Lyon, France
  Connect »

Géraldine PIGNOT, Dr

Institut Paoli-Calmettes
Marseille, France
  Connect »

Xavier RÉBILLARD, Dr

Clinique BeauSoleil
Montpellier, France
  Connect »

Olivier BOUCHOT, Dr

H tel Dieu, CHR de Nantes
Nantes, France
  Connect »

Stéphane DROUPY, Dr

CHU Caremeau, Nimes
Nimes, France
  Connect »

Evanguelos XYLINAS, Dr

H pital Cochin
Paris, France
  Connect »

Thierry LEBRET, Dr

H pital Foch
Suresnes, France
  Connect »

Mathieu ROUMIGUIE, Dr

Hopital Rangueil
Toulouse, France
  Connect »

Jacques HUBERT, Dr

CHRU Nancy
Vandœuvre-lès-Nancy, France
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.